(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

HY4PET

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

HY4PET

ST13

US500000079354552

Class

5, 10, 44

Filing

79354552

Registration

7369549

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

35

Latest update

12/01/2025

Trademark type

Word

Nice classes

5, 10, 44

Filing date

08/17/2022

Registration date

04/30/2024

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

04/30/2024

Last transaction

12/01/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

99

Owner location

NL

Examiner

FRENCH,CURTIS W

Law office

M60

Current location

FILE REPOSITORY (FRANCONIA)

Holders and representatives

Holders

Hy2Care B.V.

Representatives

Bradley M. Stohry Reichel Stohry Dean LLP

Technical classification

Nice Classes

Class 5Class 10Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical compositions for cartilage repair and treatments; pharmaceutical compositions for pain management and inflammation reduction; pharmaceutical compositions for bone repair; pharmaceutical gels for cartilage repair and treatments; pharmaceutical gels for pain management and inflammation reduction; pharmaceutical gels for bone repair; injectable pharmaceuticals for cartilage repair and treatments; injectable pharmaceuticals for pain management and inflammation reduction; injectable pharmaceuticals for bone repair; pharmaceutical products containing liquid polymers for cartilage repair and treatments; pharmaceutical products containing liquid polymers for pain management and inflammation reduction; pharmaceutical products containing liquid polymers for bone repair; pharmaceutical products containing hydrogels for cartilage repair and treatments; pharmaceutical products containing hydrogels for pain management and inflammation reduction; pharmaceutical products containing hydrogels for bone repair; advanced therapy medicinal products for cartilage repair and treatments; advanced therapy medicinal products for pain management and inflammation reduction; advanced therapy medicinal products for bone repair; advanced therapy medicinal products containing liquid polymers for cartilage repair and treatments; advanced therapy medicinal products containing liquid polymers for pain management and inflammation reduction; advanced therapy medicinal products containing liquid polymers for bone repair; advanced therapy medicinal products containing hydrogels for cartilage repair and treatments; advanced therapy medicinal products containing hydrogels for pain management and inflammation reduction; advanced therapy medicinal products containing hydrogels for bone repair; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; medicated hydrogels for cartilage repair and treatments; medicated hydrogels for pain management and inflammation reduction; medicated hydrogels for bone repair; medicated hydrogels resorbable by the animal body for cartilage repair and treatments; medicated hydrogels resorbable by the animal body for pain management and inflammation reduction; medicated hydrogels resorbable by the animal body for bone repair; pharmaceutical products for cartilage repair and treatments; pharmaceutical products for pain management and inflammation reduction; pharmaceutical products for bone repair; injectable dermal fillers; dental fillersteeth filling material; surgical glues and sealants

Class 10

Medical devicesinjection needles; medical devicessyringes; medical devices for injection of liquid components in the animal bodyinjection needles; medical devices for injection of liquid polymers in the animal bodyinjection needles; medical devices for injection of hydrogels in the animal bodyinjection needles; medical devices for supply of pharmaceutical products for cartilage repair to the animal bodyinjection instruments with needles; medical devices for supply of pharmaceutical products for bone repair to the animal bodyinjection instruments with needles; medical devices for supply of dental fillers to the animal bodyinjection needles; medical devices for supply of dental fillers to the animal bodysyringes; medical devices for application of surgical glues and sealants to the animal body; diagnostic apparatus for medical purposesultrasound diagnostic apparatus; diagnostic apparatus for medical purposesX-ray diagnostic apparatus; cell culture instruments for medical usecell culture chambers

Class 44

Medical servicescartilage repair in the animal body; medical servicespain management and inflammation reduction in the animal body; medical servicesbone repair in the animal body; dermatology services for the animal body; dentistry services for the animal body; veterinary dentistry services; surgical treatment servicessurgery of the animal body; veterinary surgical services; medical services for the diagnosis of conditions of the animal body; drug screening of the animal body for medical purposes; drug screening of the animal body for medical purposes involving application of liquid polymers; drug screening of the animal body for medical purposes involving application of hydrogels

Publications

History of USPTO decisions and trademark events.

35 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/30/2025

FICS

FINAL DISPOSITION NOTICE SENT TO IB

11/09/2025

FIMP

FINAL DISPOSITION PROCESSED

11/08/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

10/24/2025

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

06/07/2025

NREP

NEW REPRESENTATIVE AT IB RECEIVED

06/06/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/21/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/21/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/21/2025

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/21/2025

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/21/2025

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

04/30/2024

R.PR

REGISTERED-PRINCIPAL REGISTER

04/30/2024

OPNX

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

04/29/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/10/2024

OPNR

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

04/10/2024

GPNX

NOTIFICATION PROCESSED BY IB

02/14/2024

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

02/13/2024

PUBO

PUBLISHED FOR OPPOSITION

02/13/2024

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

01/24/2024

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

01/24/2024

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

01/24/2024

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

01/05/2024

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

12/28/2023

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

12/27/2023

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

12/27/2023

RFNT

REFUSAL PROCESSED BY IB

08/01/2023

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

07/12/2023

RFRR

REFUSAL PROCESSED BY MPU

07/12/2023

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

06/08/2023

CNRT

NON-FINAL ACTION WRITTEN

06/07/2023

DOCK

ASSIGNED TO EXAMINER

06/05/2023

MAFR

APPLICATION FILING RECEIPT MAILED

11/18/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/14/2022

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

11/10/2022

Continuous trademark protection

Get notified about every new filing that threatens HY4PET or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.